The international sector for Active Pharmaceutical Ingredient (API) manufacturers is a intricate landscape, covering numerous areas . The People’s Republic of China currently dominates the manufacturing of APIs, trailing India, which is a key player in both off-patent API supply . European firms , particularly in nations like Germany, Switzerland